Queen Creek Knee Care
Ask these questions before choosing care
This page answers the knee questions people often ask. You can use the answers during your visit.
An exam still matters because knees differ. Don’t delay care for fever, marked swelling or trouble standing.
Joint preservation is QC Kinetix’s term for discussing care without surgery. For PRP, the clinic team spins your blood, collects the platelet-rich portion and uses that portion in your knee.
Use the answers to compare your choices
Choose the questions that match your main worry. Bring them with your X-rays and medicine list.
Ask what likely causes the soreness. Then ask what you can try at home.
Cost, relief and cartilage change aren’t the same. Keep each answer clear before you decide.
Ask who will perform the care. The words medical provider don’t always mean doctor.
Who may be a poor fit for blood-based knee care?
Severe joint changes, a loose knee or major motion loss may call for a surgeon’s view. Infection or bleeding concerns need a full medical review first.
Can care without surgery rebuild knee cartilage?
Studies haven’t shown steady rebuilding of widely worn cartilage. Less soreness can happen without any change to the joint surface.
Does bone-on-bone wear mean surgery must happen now?
No, an X-ray alone doesn’t set the date. Your soreness, motion and daily limits help you judge timing.
What can I try at home for my knee?
Steady strength work and shorter bouts of activity may ease soreness. A brace or cane may also reduce the load.
What does regenerative medicine mean here?
The term means non-surgical care made from body material, including your blood. It doesn’t promise cartilage growth or relief.
What might this knee care cost?
Prices depend on the treatment and follow-up. Ask for a written fee that names every visit.
Will insurance cover this care?
Many blood-based knee procedures are paid in cash. Your plan may cover the exam, X-rays, therapy, braces or surgery.
How long might relief last?
There isn’t one dependable answer because people and treatments differ. Ask when the clinic will check your result and what follows if soreness returns.
Sources
-
FDA states plainly that no stem cell, exosome, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic-fluid product has been approved for the treatment of ANY orthopedic condition - it names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain individually. The only FDA-approved stem cell products in the United States are cord-blood-derived blood-forming stem cells for disorders of the hematopoietic system, and there are currently no FDA-approved exosome products.
US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. FDA, 2020.
-
The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative.
Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.
-
MACI (autologous cultured chondrocytes on a porcine collagen membrane, Vericel; STN BL 125603) IS an FDA-LICENSED cell therapy - and its approved indication is narrow and specific: repair of symptomatic, single or multiple FULL-THICKNESS cartilage defects OF THE KNEE, with or without bone involvement, in adults. It is not approved for osteoarthritis. The existence of one licensed cartilage cell therapy for focal defects is the sharpest available way to show what a licensed 'regeneration' product actually looks like, and how far it is from an injection for a worn joint.
US Food and Drug Administration, Center for Biologics Evaluation and Research — MACI (autologous cultured chondrocytes on porcine collagen membrane). FDA, 2024.
-
A randomized trial in the New England Journal of Medicine compared physical therapy against intra-articular glucocorticoid injection for knee osteoarthritis and found physical therapy produced better WOMAC outcomes at one year. When a clinic offers an injection, the comparator that matters is not 'nothing' - it is a course of supervised exercise.
Deyle GD, et al. — Physical Therapy versus Glucocorticoid Injection for Osteoarthritis of the Knee.. The New England journal of medicine, 2020. DOI: 10.1056/NEJMoa1905877.
-
A GRADE-rated systematic review and meta-analysis of 16 randomized trials (807 participants) found that MSC therapy for chronic knee OA pain PROBABLY RESULTS IN LITTLE TO NO DIFFERENCE in pain relief at 3-6 months (WMD -0.74 cm on a 10 cm VAS against a minimally important difference of 1.5 cm) or physical functioning (WMD 2.23 on the SF-36 100-point subscale against a 10-point MID), both moderate certainty; at 12 months pain was again probably little-to-no-different (WMD -0.73 cm). The measured effect is real but sits BELOW the threshold at which a patient would notice it.
Sadeghirad B, et al. — Mesenchymal stem cells for chronic knee pain secondary to osteoarthritis: A systematic review and meta-analysis of randomized trials.. Osteoarthritis and cartilage, 2024. DOI: 10.1016/j.joca.2024.04.021.
Bring clear notes to your visit
Bring your X-rays, current medicines and brief notes about soreness. Write down the daily task you most want to regain.
Plan roughly twenty-five to thirty minutes from central Queen Creek. Call the Phoenix-area clinic team at (602) 837-PAIN.
Book a free consultation